Citation

  • Authors: Kim EH. et al.
  • Year: 2020
  • Journal: Cancers 12 1203
  • Applications: in vivo / miRNA / in vivo-jetPEI

Method

Therapy was started when the tumor volume reached ~200 mm3 (Mice = Lymphoma Xenograpft Subcutaneous model)

Abstract

Backgrounds: Radioimmunotherapy (RIT) serves as a targeted therapy for non-Hodgkin lymphomas (NHL). Although HIF(Hypoxia-inducible factors)-1

Go to